Discovering a Common Goal,
Discovering a Cure

CONTACT  |  DONATE  |  E-NEWSLETTER  | 
  
DRUG NEWS

Research News
Drug News
Conference News
< Home



Catabasis Pharmaceuticals Advancing Multi-Target Approach for DMD, ALS
April 16, 2015

Cambridge, MA-based Catabasis Pharmaceuticals has developed a unique platform for engineering multi-target drug candidates that simultaneously modulate multiple disease-relevant pathways. The company is now...

New Test to Measure Mutant Huntingtin in CSF Holds Potential For Disease Diagnosis
April 16, 2015

Huntington’s disease-causing mutations in the huntingtin (mHTT) gene were first identified in 1993, but until now the mutant protein was undetectable in living patients due to its low concentration in the cerebrospinal fluid (CSF)....

Keyboard Typing Patterns May Contribute to Parkinson’s Diagnosis
April 9, 2015

An individual’s style of keyboard typing is so distinctive that it can be used as a biometric signature for security purposes. A new study out of Massachusetts Institute of Technology (MIT) suggests that this signature can also be...

Heated Debate Over Access to GM604 Continues
April 6, 2015

On March 25, 2015, ALS patients and their families held a rally on Capitol Hill demanding accelerated approval of GM604, a drug developed by California biotechnology company Genervon. The drug is a...

$100 Million Public-Private Venture Fund to Focus on Dementia Research
March 25, 2015

The difficult funding climate of NIH budget cuts and pharmaceutical companies withdrawing from early stage research and development in the neurosciences creates a need for creative funding solutions to continue to fuel the drug development...





The ALS Forum was developed by Prize4Life, Inc.
 
© 2015 Prize4Life, Inc.
Identified content provided through
a partnership with the Alzforum